Suchergebnisse - "Tian, Hongjun"

PubPharm (170)

1

Molecular mechanisms of quetiapine bidirectional regulation of bipolar depression and mania based on network pharmacology and molecular docking : Evidence from computational biology

enthalten in: Journal of affective disorders | 2024

von Li, C. | Tian, H. | Li, R. | +8

2

Gender differences in the association between childhood maltreatment and the onset of major depressive disorder

enthalten in: Journal of affective disorders | 2024

von Dong, C. | Wang, Z. | Jia, F. | +6

3

Latent classes of symptom trajectories among major depressive disorder patients in China

enthalten in: Journal of affective disorders | 2024

von Wang, Y. | Li, J. | Bian, W. | +17

4

Insulin Resistance/Diabetes and Schizophrenia : Potential Shared Genetic Factors and Implications for Better Management of Patients with Schizophrenia

enthalten in: CNS drugs | 2024

von Zhuo, C. | Zhang, Q. | Wang, L. | +6

5

Insulin Resistance/Diabetes and Schizophrenia: Potential Shared Genetic Factors and Implications for Better Management of Patients with Schizophrenia

enthalten in: CNS drugs | 2023

von Zhuo, C. | Zhang, Q. | Wang, L. | +6

6

Proinflammatory phenotype in major depressive disorder with adulthood adversity : In line with social signal transduction theory of depression

enthalten in: Journal of affective disorders | 2023

von Lin, J. | Li, J. | Kong, L. | +13

7

Low-dose lithium adjunct to quetiapine improves cognitive task performance in mice with MK801-induced long-term cognitive impairment : Evidence from a pilot study

enthalten in: Journal of affective disorders | 2023

von Zhuo, C. | Tian, H. | Zhu, J. | +7

8

Preparation method of compound efficiently-dissolved nose washing salt

enthalten in: Europäisches Patentamt | 2023

von TIAN HONGJUN

9

Preparation method of compound efficiently-dissolved nose washing salt

enthalten in: Europäisches Patentamt | 2023

von TIAN HONGJUN

10

Low-dose lithium adjunct to atypical antipsychotic treatment nearly improved cognitive impairment, deteriorated the gray-matter volume, and decreased the interleukin-6 level in drug-naive patients with first schizophrenia symptoms : a follow-up pilot study

enthalten in: Schizophrenia (Heidelberg, Germany) | 2023

von Zhuo, C. | Hu, S. | Chen, G. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]